<?xml version="1.0" encoding="UTF-8"?>
<p>Will passive immunization with plasma from convalescent patients be beneficial for treating COVID-19? Anti-S antibodies seem to protect against lethal CoV challenge and clear the virus in mice and ferrets (
 <xref rid="bib26" ref-type="bibr">Du et al., 2008a</xref>; 
 <xref rid="bib25" ref-type="bibr">Du et al., 2007</xref>; 
 <xref rid="bib27" ref-type="bibr">Du et al., 2008b</xref>; 
 <xref rid="bib31" ref-type="bibr">Fett et al., 2013</xref>). In a small experiment, SARS-CoV-2 infection reportedly protected against a second challenge of macaques, which was attributed to the development of protective antibodies (
 <xref rid="bib8" ref-type="bibr">Bao et al., 2020</xref>). The outcome of human clinical trials will, of course, outweigh animal-model experiments.
</p>
